Categories: Wire Stories

D8 Holdings Corp. Announces Pricing of Upsized $300 Million Initial Public Offering

HONG KONG–(BUSINESS WIRE)–D8 Holdings Corp. (the “Company”) announced today the pricing of its initial public offering of 30,000,000 units, upsized from 25,000,000 units, at a price of $10.00 per unit. The units will be listed on The New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “DEH.U” beginning on July 15, 2020. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “DEH” and “DEH WS,” respectively. The offering is expected to close on July 17, 2020.

D8 Holdings Corp. is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus on global and regional consumer brands.

UBS Investment Bank is acting as the sole book running manager of the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on July 14, 2020. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering is being made only by means of a prospectus. When available, copies of the prospectus relating to this offering may be obtained from UBS Securities LLC, Attn: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, or by telephone at (888) 827-7275, or by e-mail at olprospectusrequest@ubs.com.

Cautionary Note Concerning Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement for the initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts

George Ho

D8 Holdings Corp.

+852 3973 5500

George.ho@d8holdingscorp.com

Alex

Recent Posts

Getting Ready: LUX Helps Female Ex-Offenders Reintegrate Back to Society

LUX Launches ‘Getting Ready’ Campaign to Inspire Ex-offenders to Re-embrace Beauty and Re-enter Society with…

31 mins ago

PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA

SEOUL, South Korea--(BUSINESS WIRE)--#AcuteMyeloidLeukemia--PROTEINA announced today that it has held a kickoff meeting with Professor…

59 mins ago

Nordson Electronics Solutions Receives EM China Innovation Award for the New ASYMTEK Select Coat® SL-1040 Conformal Coating System

Recognized at the Productronica China tradeshow, the SL-1040 elevates coating performance with improved yield and…

3 hours ago

Hong Kong Ups the Game with New Incentive Playbook

Largest Celebration Ever with Over 110 Agents from Eight Markets to Experience Ultimate Hong Kong…

3 hours ago

DTEN’s Next Generation Video Conferencing and Collaboration Device for Zoom and Microsoft Teams, Now available in South Korea

DTEN’s Flagship D7X All-in-One Solution is Now KC and KCC Certified in South Korea, Delivering…

4 hours ago

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA)…

5 hours ago